ID   SUSMi005-A-2.1
AC   CVCL_C0GU
SY   SNCA3X 1KO C1
DR   BioSamples; SAMEA12312966
DR   hPSCreg; SUSMi005-A-2
DR   Wikidata; Q112930437
RX   PubMed=35263701;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 11138; SNCA (Note=1 of 4 alleles).
CC   Sequence variation: Gene amplification; HGNC; 11138; SNCA; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 30-01-24; Version: 5
//
RX   PubMed=35263701; DOI=10.1016/j.scr.2022.102733;
RA   Zafar F., Nallur Srinivasaraghavan V., Chen M.Y., Morato Torres C.A.,
RA   Schule B.;
RT   "Isogenic human SNCA gene dosage induced pluripotent stem cells to
RT   model Parkinson's disease.";
RL   Stem Cell Res. 60:102733-102733(2022).
//